Analytical Data
-
基因名
SOS1
- Application
-
别名
Son of sevenless homolog 1. SOS-1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q07889
-
表达区间
1-313-420 aa
-
氨基酸序列
SQLSKPGAALYLQSIGEGFKEAVQYVLPRLLLAPVYHCLHYFELLKQLEEKSEDQEDKECLKQAITALLNVQSGMEKICSKSLAKRRLSESACRFYSQQMKGKQLAIK
-
分子量
37.62 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SOS1 (Son of Sevenless 1) is a crucial protein involved in the Ras signaling pathway, which plays a significant role in cell proliferation, differentiation, and survival. The protein functions as a guanine nucleotide exchange factor (GEF) that specifically activates Ras proteins, thereby influencing various cellular processes and signaling cascades. Mutations or dysregulation of SOS1 have been associated with several types of cancers and developmental disorders, making it a potential therapeutic target. Additionally, SOS1 is implicated in conditions like Noonan syndrome and cardio-facio-cutaneous syndrome, where its aberrant signaling contributes to pathophysiology. Given its central role in mediating Ras activation, the study of SOS1 and the development of recombinant SOS1 proteins have gained considerable interest in both basic research and clinical applications. Researchers aim to elucidate the structural and functional mechanisms of SOS1, to devise strategies for modulating its activity in disease contexts, and to explore its interactions with other cellular components. The development of SOS1 recombinant proteins facilitates high-throughput screening for small-molecule inhibitors or activators, providing insights into therapeutic possibilities for conditions where Ras signaling is misregulated. Therefore, ongoing research into SOS1 recombinant proteins holds promise for enhancing our understanding of cancer biology and other related disorders, ultimately aiming to advance targeted therapeutic approaches.












